Name: ABSA’s 1st Biosecurity Symposium
Start: 2021-04-20T00:00:00-05:00
End: 2021-04-23T23:59:59-05:00
Location: Renaissance Depot Hotel

Titanium–Gadolinium Quantum Dot Staining Agent Specific to Bacterial Cells

by Global Biodefense Staff April 25, 2020, 8:40 am
Implementation of Stringent Social Distancing to Prevent Transmission of COVID-19 in Senior Living Communities

by Global Biodefense Staff April 5, 2020, 9:23 am
Hydroxychlorquine and Azythromycine Combination Treatment for COVID-19 Can Raise Risk for Dangerous Abnormal Heart Rhythms

by Global Biodefense Staff April 2, 2020, 12:19 pm
Singapore: Seven Clusters of COVID-19 Cases Suggesting Presymptomatic Transmission

by Global Biodefense Staff April 1, 2020, 9:31 am
COVID-19 Infection in Children

by Global Biodefense Staff March 29, 2020, 12:13 pm
SARS-CoV-2 Infection in Children – NEJM

by Global Biodefense Staff March 22, 2020, 5:25 pm
Virus Shedding in Rhesus Macaques Innoculated with SARS-CoV-2

by Global Biodefense Staff March 22, 2020, 2:10 pm
Lopinavir-Ritonavir Does Not Offer Substantial Benefit in Severe COVID-19

by Global Biodefense Staff March 18, 2020, 10:21 pm
Serological Assay to Detect SARS-CoV-2 Seroconversion in Humans

by Global Biodefense Staff March 18, 2020, 12:53 pm
The Proximal Origin of SARS-CoV-2

by Global Biodefense Staff March 17, 2020, 8:35 pm
LJI Scientists Identify Potential Targets for Immune Responses to SARS-CoV-2

by Global Biodefense Staff March 15, 2020, 2:06 pm
COVID-19 and Italy: What Next?

by Global Biodefense Staff March 14, 2020, 4:45 pm
Critical Bioeconomy Asset in Need of Attention: BSL-3 and BSL-4 Laboratories in the U.S.

by Global Biodefense Staff March 6, 2020, 3:02 pm
CCD Detector System for Abrin Toxin Activity

by Global Biodefense Staff March 6, 2020, 2:05 pm

Congratulations. You've reached the end of the internet.

Archives: Research

Titanium–Gadolinium Quantum Dot Staining Agent Specific to Bacterial Cells

Hydroxychlorquine and Azythromycine Combination Treatment for COVID-19 Can Raise Risk for Dangerous Abnormal Heart Rhythms

Singapore: Seven Clusters of COVID-19 Cases Suggesting Presymptomatic Transmission

COVID-19 Infection in Children

SARS-CoV-2 Infection in Children – NEJM

Virus Shedding in Rhesus Macaques Innoculated with SARS-CoV-2

Lopinavir-Ritonavir Does Not Offer Substantial Benefit in Severe COVID-19

Serological Assay to Detect SARS-CoV-2 Seroconversion in Humans

The Proximal Origin of SARS-CoV-2

LJI Scientists Identify Potential Targets for Immune Responses to SARS-CoV-2

COVID-19 and Italy: What Next?

Critical Bioeconomy Asset in Need of Attention: BSL-3 and BSL-4 Laboratories in the U.S.

CCD Detector System for Abrin Toxin Activity

Biodefense Headlines – 21 January 2021

First Cases of B.1.1.7 Variant COVID-19 Detected in Washington State

The Response Measures Database: Central Archive of COVID-19 Interventions

EU Initiative on Health Security Work Programme 2021

Rapid Identification of Ricin in Serum Samples Using LC–MS/MS

Dr. Fauci Makes First Appearance at Biden White House Press Briefing – Transcript

ASM Expresses Support for the Global Health Security Act of 2021

How and When Will Lower-Income Countries Gain Access to COVID-19 Vaccines?

OHDSI Awarded $10M FDA Contract to Monitor Safety and Effectiveness of Vaccines, Biologics

Neutralizing Norovirus: NIAID Monoclonal Antibodies Licensing Opportunity

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats

Emerging Infections Network – Managing Travelers Who Acquire Disease Abroad

Upcoming Events

Application Deadline: Expanding Existing Research Grants, CRADAs for Novel Coronavirus Response

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 2

Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 3

ABSA’s 1st Biosecurity Symposium

Latest Articles